Detalhe da pesquisa
1.
Integrative analyses reveal outcome-associated and targetable molecular partnerships between TP53, BRD4, TNFRSF10B, and CDKN1A in diffuse large B-cell lymphoma.
Ann Hematol
; 103(1): 199-209, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792064
2.
Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomas.
Hematol Oncol
; 41(4): 644-654, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37254453
3.
FAM171B is a novel polyglutamine protein widely expressed in the mammalian brain.
Brain Res
; 1766: 147540, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34052262
4.
Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL.
Leukemia
; 35(2): 522-533, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32139889
5.
Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.
Blood Cancer J
; 10(11): 117, 2020 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33168821